Positives

• Patients drawn to mitochondrial peptides describe humanin as biologically interesting because it is a mitochondria-encoded cytoprotective peptide implicated in healthspan.
  
  
• One patient reported subjective resilience improvements when stacking humanin analog protocols with other mitochondrial support, though the signal is hard to isolate.
  
  

Negatives

• Patients note that almost all evidence is preclinical and that human dosing protocols are not established.
  
  
• A patient reported uncertainty about whether perceived benefits were real or part of broader stack effects.
  
  

Hurdles & Side Effects

• Humanin and its analogs are not FDA-approved and exist almost entirely in research settings.
  
  
• Patients describe scarce, expensive grey-market sourcing with no purity assurance.